Forward Pharma A Probability of Future Stock Price Finishing Under 2.56
| FWPDelisted Stock | USD 2.56 0.00 0.00% |
Forward |
Forward Pharma Target Price Odds to finish below 2.56
The tendency of Forward Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 2.56 | 90 days | 2.56 | about 49.09 |
Based on a normal probability distribution, the odds of Forward Pharma to move below current price in 90 days from now is about 49.09 (This Forward Pharma A probability density function shows the probability of Forward Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Forward Pharma A has a beta of -0.16. This usually indicates as returns on the benchmark increase, returns on holding Forward Pharma are expected to decrease at a much lower rate. During a bear market, however, Forward Pharma A is likely to outperform the market. Additionally Forward Pharma A has an alpha of 0.1369, implying that it can generate a 0.14 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Forward Pharma Price Density |
| Price |
Predictive Modules for Forward Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Forward Pharma A. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Forward Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Forward Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Forward Pharma is not an exception. The market had few large corrections towards the Forward Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Forward Pharma A, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Forward Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.14 | |
β | Beta against Dow Jones | -0.16 | |
σ | Overall volatility | 0.49 | |
Ir | Information ratio | -0.0016 |
Forward Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Forward Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Forward Pharma A can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Forward Pharma A is not yet fully synchronised with the market data | |
| Forward Pharma A has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (1.89 M) with profit before taxes, overhead, and interest of 0. | |
| Forward Pharma A has about 70.77 M in cash with (2.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Forward Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Forward Stock often depends not only on the future outlook of the current and potential Forward Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Forward Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7 M | |
| Cash And Short Term Investments | 70.8 M |
Forward Pharma Technical Analysis
Forward Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Forward Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Forward Pharma A. In general, you should focus on analyzing Forward Stock price patterns and their correlations with different microeconomic environments and drivers.
Forward Pharma Predictive Forecast Models
Forward Pharma's time-series forecasting models is one of many Forward Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Forward Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Forward Pharma A
Checking the ongoing alerts about Forward Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Forward Pharma A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Forward Pharma A is not yet fully synchronised with the market data | |
| Forward Pharma A has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (1.89 M) with profit before taxes, overhead, and interest of 0. | |
| Forward Pharma A has about 70.77 M in cash with (2.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Forward Stock
If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |